Biodesix Inc (BDSX): Next-Year EPS Estimate 39.68%
As of 2026-06-11, Biodesix Inc (BDSX) has a next-year EPS growth estimate of 39.68%.
On 2026-06-07, analyst consensus for BDSX's next-year EPS growth shifted from 39.67% to 39.68% — a positive change of 0.01 percentage points. The revised estimate has been sustained across 5 subsequent trading sessions. Current-year growth is projected at 35.32%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- EPS growth next year
- 39.68%
- EPS growth this year
- 35.32%
- EPS next quarter (est)
- -$0.92
- Last price
- $14.80
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 39.68% | 35.32% | -$0.92 | $14.80 |
| 2026-06-10 | 39.68% | 35.32% | -$0.92 | $15.01 |
| 2026-06-09 | 39.68% | 35.32% | -$0.92 | $15.36 |
| 2026-06-08 | 39.68% | 35.32% | -$0.92 | $14.95 |
| 2026-06-07 | 39.68% | 35.32% | -$0.92 | $15.46 |
| 2026-06-04 | 39.67% | 35.33% | -$0.92 | $16.50 |
| 2026-06-03 | 39.67% | 35.33% | -$0.92 | $16.10 |
| 2026-06-02 | 39.67% | 35.33% | -$0.92 | $15.44 |
| 2026-06-01 | 39.67% | 35.33% | -$0.92 | $15.27 |
| 2026-05-31 | 39.67% | 35.33% | -$0.92 | $16.32 |
| 2026-05-28 | 39.67% | 35.33% | -$0.92 | $15.99 |
| 2026-05-27 | 39.67% | 35.33% | -$0.92 | $14.81 |
| 2026-05-26 | 39.67% | 35.33% | -$0.92 | $14.81 |
| 2026-05-25 | 39.67% | 35.33% | -$0.92 | $14.93 |
| 2026-05-24 | 39.67% | 35.33% | -$0.92 | $14.93 |
| 2026-05-21 | 39.67% | 35.33% | -$0.92 | $15.18 |
| 2026-05-20 | 39.67% | 35.33% | -$0.92 | $14.37 |
| 2026-05-19 | 39.67% | 35.33% | -$0.92 | $13.94 |
| 2026-05-18 | 39.67% | 35.33% | -$0.92 | $14.25 |
| 2026-05-17 | 39.67% | 35.33% | -$0.92 | $14.17 |
| 2026-05-14 | 39.67% | 35.33% | -$0.92 | $14.76 |
| 2026-05-13 | 39.67% | 35.33% | -$0.92 | $14.86 |
| 2026-05-12 | 39.67% | 35.33% | -$0.92 | $15.75 |
| 2026-05-11 | 39.67% | 35.33% | -$0.92 | $16.11 |
| 2026-05-10 | 39.67% | 35.33% | -$0.92 | $15.32 |
| 2026-05-07 | 39.67% | 35.33% | -$0.92 | $15.47 |
| 2026-05-06 | 39.67% | 35.33% | -$0.92 | $15.00 |
| 2026-05-05 | 40.80% | 33.88% | -$0.91 | $14.94 |
| 2026-05-04 | 36.98% | 34.27% | -$1.13 | $11.27 |
| 2026-05-03 | 36.98% | 34.27% | -$1.13 | $11.08 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Biodesix Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Biodesix Inc (BDSX) has a next-year EPS growth estimate of 39.68%, based on analyst consensus.
When was the latest EPS estimate revision for BDSX?▾
The most recent revision occurred on 2026-06-07, when analysts adjusted the next-year EPS growth estimate from 39.67% to 39.68%.
What sector and industry does Biodesix Inc belong to?▾
Biodesix Inc operates in the Healthcare sector, specifically the Diagnostics & Research industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. BDSX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Biodesix Inc (BDSX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports